Modulation of MHC gene expression in human breast carcinoma cells by hormones - PubMed (original) (raw)
Modulation of MHC gene expression in human breast carcinoma cells by hormones
M Teh et al. J Immunogenet. 1989 Aug-Oct.
Abstract
Products encoded by the class I Major Histocompatibility Complex (MHC) genes serve as restriction molecules which enable T cells to generate an immune response to specific antigens. Recently, many investigators have demonstrated the importance of class I antigens in enabling the host to regulate tumor growth in vivo. In this report, we have studied the regulation of HLA genes by hormones in human breast cancer cell lines. Eight lines were studied. Using HLA locus-specific DNA probes, the level of HLA-A and HLA-B specific mRNAs were found to be underrepresented in six of these cell lines when compared to an epithelial cell line derived from a normal lactating breast. Moreover, the expression of class I MHC mRNA in these cells correlated well with the level of chloramphenicol acetyltransferase (CAT) activity detected after the introduction of exogenous HLA-CAT DNA-constructs. It was also found that HLA expression in some of the breast carcinoma cell lines could be modulated by the addition of hormones. Hence, HLA mRNA expression in the cell line MCF-7 was enhanced by the addition of estrogen; but was down-regulated in the presence of dexamethasone. Conversely, for T-47D cells, HLA expression was suppressed by progesterone. These results indicate that hormones could have an influence on the expression of HLA genes and may therefore indirectly be involved in the regulation of tumor growth by the host's immune system.
Similar articles
- Downmodulation of HLA class I expression by dexamethasone in MCF-7 cell line.
Rodríguez F, Redondo M, Hortas-Nieto ML, Téllez-Santana T, Pérez-Valero V, Ruiz-Cabello F. Rodríguez F, et al. Rev Esp Fisiol. 1997 Dec;53(4):355-60. Rev Esp Fisiol. 1997. PMID: 9542773 - Identification of locus-specific DNA-binding factors for the regulation of HLA class-I genes in human colorectal cancer.
Soong TW, Hui KM. Soong TW, et al. Int J Cancer Suppl. 1991;6:131-7. doi: 10.1002/ijc.2910470724. Int J Cancer Suppl. 1991. PMID: 2066178 - Dexamethasone induces altered binding of regulatory factors to HLA class I enhancer sequence in MCF-7 breast tumour cell line.
Rodriguez F, Redondo M, Ruiz-Cabello F. Rodriguez F, et al. Cancer Immunol Immunother. 1998 Jun;46(4):194-200. doi: 10.1007/s002620050478. Cancer Immunol Immunother. 1998. PMID: 9671142 Free PMC article. - The role of surface HLA-A,B,C molecules in tumour immunity.
Möller P, Hämmerling GJ. Möller P, et al. Cancer Surv. 1992;13:101-27. Cancer Surv. 1992. PMID: 1423320 Review. - The genetics of HLA.
Schwartz DW, Felser B, Mayr WR. Schwartz DW, et al. Folia Biol (Praha). 1995;41(3-4):123-39. Folia Biol (Praha). 1995. PMID: 7589710 Review. No abstract available.
Cited by
- A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.
Boegel S, Löwer M, Bukur T, Sahin U, Castle JC. Boegel S, et al. Oncoimmunology. 2014 Aug 3;3(8):e954893. doi: 10.4161/21624011.2014.954893. eCollection 2014. Oncoimmunology. 2014. PMID: 25960936 Free PMC article. - Upmodulation by estrogen of HLA class I expression in breast tumor cell lines.
Rodríguez F, Perán F, Garrido F, Ruiz-Cabello F. Rodríguez F, et al. Immunogenetics. 1994;39(3):161-7. doi: 10.1007/BF00241256. Immunogenetics. 1994. PMID: 8276464
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous